CONFERENCE SPEAKERS

Speakers
Megan Sutton
Megan Sutton
Senior Medical Director, Clinical Development and Real-world Evidence,
Lexeo Therapeutics

Megan Sutton, DNP, ACNP-BC, is an experienced Clinician and accomplished Strategic Pharmaceutical Leader with an extensive career spanning over two decades. Beginning as a dedicated Nurse Practitioner, she gained valuable experience in patient care for over a decade before transitioning to the pharmaceutical industry. Throughout her career, Megan has been involved in the successful launch of three innovative therapies, including ENTRESTO® for Heart Failure, ANDEXXA® for Factor Xa Inhibitor reversal, and CAMZYOS® for Hypertrophic Cardiomyopathy, significantly impacting patient care on a global scale. Her roles in the pharmaceutical landscape have been diverse, encompassing Medical Affairs, Real-World Evidence (RWE), and Clinical Development.  Presently, Megan holds the position of Senior Medical Director and Clinical Lead for a pioneering Gene Therapy trial focused on a rare genetic cardiomyopathy, contributing to innovative research aimed at improving patient outcomes.


Adrian Kielhorn
Adrian Kielhorn
Senior Director, Global HEOR Neurology,
Alexion Pharmaceuticals, Inc


Amit Kulkarni
Amit Kulkarni
Head of Health Economic Modeling and Decision Sciences,
Otsuka Pharmaceutical Companies